As cancer care becomes increasingly driven by complex, high-cost therapies, health systems are rethinking how tightly ...

The theme of our inaugural regional Institute for Value-Based Medicine® event in Boston was, “Elevating Value in Cancer Care,” and one of the 4 panel discussions focused on the important contributions ...

Oncology pharmacists now work alongside providers to improve efficiency, patient education, and treatment outcomes, according to Scott Soefje, PharmD, MBA, BCOP. He expanded on this topic during the ...

Immunotherapy for Head and Neck Squamous Cell Carcinoma: Present and Future Approaches and Challenges A retrospective study was conducted to observe outcomes in patients discharged from the hematology ...

As cell and gene therapies move into mainstream care, pharmacy leaders say health systems are confronting a shared reality: While they may be clinically prepared, their infrastructure might be ...

Program success based on proactive, high-touch engagement with provider community, as measured by new-start prior authorizations of oncology biosimilar compared to reference product Additional savings ...

Please provide your email address to receive an email when new articles are posted on . BOSTON – The Hematology/Oncology Pharmacy Association Annual Meeting offered the opportunity to learn about ...

CURE® spoke with the director of oncology pharmacy at Massachusetts General Hospital about recent cancer drug shortages that have been making headlines. Drug shortages are, unfortunately, not new to ...

Jina Yun is an Oncology Pharmacy Resident in the PGY2 program at the UW Medicine Department of Pharmacy Services in Seattle. In this role, she is completing her training as a clinical pharmacist ...

Health plans are making the switch to lower-cost biosimilars while maintaining high-quality of care for members Program success based on proactive, high-touch engagement with provider community, as ...